PROCEPT BioRobotics Corporation
PRCT
$35.86
$0.431.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 83.33M | 79.18M | 69.16M | 68.24M | 58.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 83.33M | 79.18M | 69.16M | 68.24M | 58.37M |
| Cost of Revenue | 29.32M | 27.44M | 25.00M | 24.56M | 21.46M |
| Gross Profit | 54.01M | 51.75M | 44.16M | 43.67M | 36.91M |
| SG&A Expenses | 59.01M | 56.30M | 55.20M | 48.32M | 42.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 106.52M | 101.37M | 96.60M | 87.95M | 80.80M |
| Operating Income | -23.19M | -22.19M | -27.44M | -19.71M | -22.43M |
| Income Before Tax | -21.41M | -19.58M | -24.74M | -18.86M | -20.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.41M | -19.58M | -24.74M | -18.86M | -20.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.41M | -19.58M | -24.74M | -18.86M | -20.97M |
| EBIT | -23.19M | -22.19M | -27.44M | -19.71M | -22.43M |
| EBITDA | -21.57M | -20.60M | -25.96M | -18.26M | -21.10M |
| EPS Basic | -0.38 | -0.35 | -0.45 | -0.35 | -0.40 |
| Normalized Basic EPS | -0.24 | -0.22 | -0.28 | -0.22 | -0.25 |
| EPS Diluted | -0.38 | -0.35 | -0.45 | -0.35 | -0.40 |
| Normalized Diluted EPS | -0.24 | -0.22 | -0.28 | -0.22 | -0.25 |
| Average Basic Shares Outstanding | 55.73M | 55.45M | 54.92M | 53.84M | 52.01M |
| Average Diluted Shares Outstanding | 55.73M | 55.45M | 54.92M | 53.84M | 52.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |